Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Atech Capital is a venture capital firm founded in 2019, headquartered in Sydney, Australia, with a second office located in Shenzhen, China. The firm focuses on investing in medical technology startups, particularly those addressing serious disease areas such as cancer and heart disease. Atech Capital aims to support Australian medtech founders by providing not only capital but also access to a robust network for market entry and manufacturing in Asia, especially in China.
Since its inception, Atech Capital has positioned itself as a key player in the medtech sector, targeting early and growth stage investments. The firm emphasizes high-barrier-to-entry technologies, which are essential for scaling in competitive markets. Despite being relatively new, Atech Capital has established a clear focus on helping startups navigate the complexities of entering the Asian market.
Atech Capital specializes in early and growth stage investments within the medtech sector, with a particular emphasis on serious disease areas such as cancer, heart disease, and both pediatric and adult medical devices. The firm targets startups that possess high-barrier-to-entry technologies, which are crucial for success in the competitive healthcare landscape. Atech Capital's investment strategy is designed to partner with founders who are not only innovative but also have the potential to scale their solutions into the Asian market.
The firm typically invests between $100,000 and $3 million AUD, focusing on Australian medtech startups with aspirations for global expansion. Atech Capital leverages its Shenzhen-based partnerships to facilitate market entry and manufacturing, providing significant value beyond just capital investment. This strategic support is vital for startups looking to establish a foothold in Asia, particularly in China, where the healthcare market is rapidly evolving.
Tony Sun — Senior Partner at Atech Capital, Tony has over 27 years of experience in financial services. His background includes significant expertise in venture capital and investment management, making him a key figure in guiding the firm's investment strategy.
As of now, Atech Capital has not publicly disclosed any recent investments or activities. The firm's website is currently for sale, which raises questions about its operational status and future engagement in the venture capital space.
What are Atech Capital's investment criteria?
Atech Capital focuses on early and growth stage investments in the medtech sector, specifically targeting startups that address serious diseases such as cancer and heart disease. They look for companies with high-barrier-to-entry technologies that can scale effectively in the Asian market.
How can founders pitch to Atech Capital?
Founders interested in pitching to Atech Capital should prepare a detailed presentation that outlines their technology, market potential, and growth strategy. While specific submission guidelines are not publicly available, a clear articulation of how their startup aligns with Atech's focus on medtech and Asian market entry is essential.
What makes Atech Capital different from other VC firms?
Atech Capital differentiates itself through its strong emphasis on the medtech sector and its unique access to the Asian market, particularly through partnerships in Shenzhen. This provides portfolio companies with critical resources for market entry and manufacturing.
What is the geographic focus of Atech Capital?
The firm primarily invests in Australian medtech startups but has a strong focus on helping these companies expand into the Asian market, especially China. This geographic strategy is integral to their investment thesis.
What is the typical check size for investments?
Atech Capital typically invests between $100,000 and $3 million AUD in its portfolio companies, depending on the specific needs and growth stage of the startup.
What kind of post-investment support does Atech Capital provide?
Beyond capital, Atech Capital offers significant value-add through its extensive network for market entry and manufacturing in Asia. This support is crucial for startups looking to scale their operations effectively in the region.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.